skinbetter science

Session on Saturday, November 14 at 13:45

skinbetter science was formed in 2016 to establish a new biotech-based paradigm in skincare. Our innovative approach is built on three pillars: a technology pipeline of scientific innovation across multiple skincare categories, rigorous clinical substantiation of the safety and efficacy of the products developed from these novel technologies, and a partnership with dermatologists, plastic surgeons, and other healthcare professionals in the aesthetic medical community to deliver best-in-class skincare solutions to their patients.

At skinbetter science, our leadership’s rich heritage in dermatologic and aesthetic medicine informs our entire approach to identifying unmet skincare needs in the market, discovering and developing breakthrough technologies to address those needs, and researching and testing these breakthroughs to the highest standards of clinical and scientific validation. This commitment to advancing patient care through the study of skincare science remains at the core of our brand as we proudly are a member of the L’Oréal Dermatological Beauty family since 2022.

skinbetter science products are available in Canada only through our ever-growing network of authorized aesthetic clinics. Our iconic AlphaRet Overnight Cream, formulated in 2016 and since 2024 available in Canada, engineered to deliver retinoid efficacy whislt being ultra tolerable, has opened a new frame of treatment solutions for physicians and patients. (peut etre rajouter un blabla sympa sur alpharet)

Visit website

Sessions at Dermatology Update — Fall 2026

1 session

Saturday, November 1413:45 – 14:1530 minOpen Pres.

From Daily Skincare to Procedural Care: New Perspectives on Topical Retinoid Tolerability

Chair

Dr. Jensen Yeung

Speakers

Dr. Sonya Abdulla

Tolerability is a key consideration in topical retinoid use, particularly for patients reporting previous intolerance and those undergoing aesthetic procedures. This symposium brings together emerging clinical evidence and Canadian case experiences to explore a topical retinoid formulation in both daily skincare and peri-procedural care. Through clinical findings and patient photography, speakers will discuss observed tolerability and skin-quality outcomes, including use alongside microneedling and fractional non-ablative laser across diverse skin phototypes.

Learning objectives

Evaluate tolerability and photoaging outcomes from a 12-week, multicentre, open-label study of a topical retinoid formulation in individuals with self-perceived retinoid intolerance.
Examine peri-procedural tolerability and skin-quality outcomes from a Canadian case series evaluating the same formulation alongside microneedling and fractional non-ablative laser in participants with diverse skin phototypes.
Critically appraise the clinical relevance and limitations of these findings, including formulation-specific considerations in interpreting topical retinoid tolerability and peri-procedural use.

Toronto BallroomSee it in the program